Core Laboratories CLB Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | 10.7%-0.5pp | 11.2%+0.5pp | 10.7%+2.2pp | 8.6%-1.1pp | |
| Net margin | 5.6%-0.4pp | 6%-1.2pp | 7.2%+2.8pp | 4.4%+0.2pp | |
| EBITDA margin | 13.5%-0.5pp | 14%+0.2pp | 13.8%+1.8pp | 12.1%-1.5pp | |
| Free cash flow margin | 4.9%-3.6pp | 8.5%+5.7pp | 2.8%— | —— | |
| Returns | |||||
| Return on equity | 11.6%-1.7pp | 13.3%-4.6pp | 17.9%— | —— | |
| Return on assets | 5.1%-0.3pp | 5.4%-0.9pp | 6.3%+2.6pp | 3.7%— | |
| Return on invested capital | 9.2%-0.6pp | 9.8%-2.2pp | 12%— | —— | |
| Efficiency | |||||
| Asset turnover | 0.9×0.0× | 0.9×0.0× | 0.9×0.0× | 0.8×— | |
| Liquidity | |||||
| Current ratio | 2×-0.1× | 2.2×-0.4× | 2.5×+0.5× | 2.1×— | |
| Quick ratio | 1.5×-0.1× | 1.6×-0.1× | 1.7×+0.3× | 1.5×— | |
| Cash ratio | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.1×— | |
| Leverage | |||||
| Debt-to-equity | 0.6×-0.1× | 0.7×-0.2× | 1×-0.2× | 1.2×— | |
| Debt-to-assets | 0.3×0.0× | 0.3×-0.1× | 0.4×0.0× | 0.4×— | |
| Net debt / EBITDA | 2×-0.2× | 2.2×-0.7× | 2.8×-0.7× | 3.5×— | |
| Interest coverage | 5.3×+0.6× | 4.7×+0.7× | 4.1×+0.4× | 3.6×-1.3× | |
| Valuation | |||||
| Market capitalization | $492.77M-9.3% | $812.71M-1.4% | $824.09M-12.3% | $939.95M-9.0% | |
| Enterprise value | $637.8M-7.6% | $973.69M-4.9% | $1.02B-10.7% | $1.15B— | |
| Price / earnings | 17×-1.4× | 25.9×+3.4× | 22.5×-21.6× | 44×-8.3× | |
| Price / sales | 0.9×-0.1× | 1.6×-0.1× | 1.6×-0.3× | 1.9×-0.3× | |
| Price / book | 1.8×-0.2× | 3.3×-0.4× | 3.7×-1.4× | 5.1×— | |
| EV / EBITDA | 9.3×-0.8× | 13.2×-1.3× | 14.5×-4.9× | 19.4×— | |
| EV / sales | 1.2×-0.1× | 1.9×-0.2× | 2×-0.3× | 2.3×— | |
| Free cash flow yield | 4.6%-3.2pp | 5.5%+3.8pp | 1.7%— | —— | |
| Earnings yield | 5.9%+0.4pp | 3.9%-0.6pp | 4.5%+2.2pp | 2.3%+0.4pp | |
| Dividend yield | 0.4%0.0pp | 0.2%0.0pp | 0.2%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Core Laboratories's ratios come from?
- Every ratio is computed from Core Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
